PsychoactiveMap

Terminated psychedelic research trials

Data as of 31 October 2026. Source: ClinicalTrials.gov records held by PsychoactiveMap, refreshed from a reviewed snapshot.

Terminated is a registry status. The study stopped early and will not start again. Status is reported by the study team and can change.

Educational information, not medical advice. A registry listing is not evidence of safety, benefit or results, and it is not a recommendation. PsychoactiveMap does not recruit, screen or refer participants. Status and other details are copied from the registry and can be out of date, so check the registry record and speak to a qualified health professional before any decision. Read the full disclaimer.

At a glance

Which substances

Counts per substance hub. Ketamine is limited to studies classified as psychiatric research, and records about disease-modifying therapy that match the abbreviation DMT are removed.

Substance hubStudies
Psilocybin7
MDMA4
LSD1
DMT1
5-MeO-DMT3
Ketamine40

By phase

PhaseStudiesShare
Early Phase 124%
Phase 11630%
Phase 22343%
Phase 4611%
Not applicable47%
Not reported36%

Countries

Country is taken from the study's linked research site. 2 of 54 records have no country on file. The top 9 countries are shown.

CountryStudiesShare
United States3870%
Canada47%
United Kingdom47%
Ireland24%
Switzerland12%
Denmark12%
Israel12%
Netherlands12%
Norway12%

Registry-listed start years

Start yearStudies
2024 and later7
2020 to 202318
2015 to 201911
2010 to 201414
Before 20104

Study design

Topics named in study titles

A keyword match on registered titles, so one study can appear under more than one topic and a study can be missed. It describes what titles mention, nothing more.

TopicStudies
Depression and mood24
Cancer and end of life5
Suicidal thoughts5
Trauma and PTSD4
Other substance use3
Pain and headache3
Obsessive-compulsive disorder3
Anxiety2

Latest registry-listed start dates

The 25 studies with the latest start dates, newest first. Dates may be estimated, including future dates; a listed date does not confirm that a study started. The order is not a ranking. Each ID links to its own ClinicalTrials.gov record.

Registry IDTitle as registeredStatusPhaseCountryRegistry dates
NCT05803551A Study of Ketamine Infusions to Treat Clinically-depressed ICU PatientsTerminatedPhase 2United StatesSource start: 2025-07-07 (actual)
Source date details

Start: 2025-07-07 (precision: day; source type: ACTUAL; actual)

Primary completion: 2026-07-01 (precision: day; source type: ACTUAL; actual)

Study completion: 2026-07-15 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:16.639Z; registry revision: 2026-08-12 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT06624137Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic PsychedelicsTerminatedNot reportedUnited StatesSource start: 2024-12-12 (actual)
Source date details

Start: 2024-12-12 (precision: day; source type: ACTUAL; actual)

Primary completion: 2026-06-14 (precision: day; source type: ACTUAL; actual)

Study completion: 2026-06-14 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:17.720Z; registry revision: 2026-07-09 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT06511947Pharmacokinetics of GH001 Delivered Via a Proprietary Aerosol Delivery Device in Healthy SubjectsTerminatedPhase 1United KingdomSource start: 2024-08-01 (actual)
Source date details

Start: 2024-08-01 (precision: day; source type: ACTUAL; actual)

Primary completion: 2026-03-23 (precision: day; source type: ACTUAL; actual)

Study completion: 2026-03-23 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:17.400Z; registry revision: 2026-10-09 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT05910775Role Of Non-Specific Effects in The Treatment of Depression With EsketamineTerminatedNot applicableUnited StatesSource start: 2024-07-13 (actual)
Source date details

Start: 2024-07-13 (precision: day; source type: ACTUAL; actual)

Primary completion: 2024-12-31 (precision: day; source type: ACTUAL; actual)

Study completion: 2024-12-31 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:16.980Z; registry revision: 2026-01-14 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT06111339Ketamine for OUD and Suicidal Ideation in the EDTerminatedPhase 2United StatesSource start: 2024-06-14 (actual)
Source date details

Start: 2024-06-14 (precision: day; source type: ACTUAL; actual)

Primary completion: 2025-03-11 (precision: day; source type: ACTUAL; actual)

Study completion: 2025-03-31 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:17.019Z; registry revision: 2025-04-08 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT06431386Behavioural Activation Therapy and Esketamine for Resistant DepressionTerminatedNot applicableCanadaSource start: 2024-06-11 (actual)
Source date details

Start: 2024-06-11 (precision: day; source type: ACTUAL; actual)

Primary completion: 2025-09-17 (precision: day; source type: ACTUAL; actual)

Study completion: 2025-09-17 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:17.400Z; registry revision: 2025-10-01 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT06077487Ketamine-assisted Therapy for Advanced GI CancerTerminatedPhase 4United StatesSource start: 2024-05-17 (actual)
Source date details

Start: 2024-05-17 (precision: day; source type: ACTUAL; actual)

Primary completion: 2025-01-31 (precision: day; source type: ACTUAL; actual)

Study completion: 2025-01-31 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:17.019Z; registry revision: 2025-05-21 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT06001372Ketamine-assisted Psychotherapy (KAP) for Patients With Existential Distress Associated With Non-operable GI CancersTerminatedEarly Phase 1United StatesSource start: 2023-10-13 (actual)
Source date details

Start: 2023-10-13 (precision: day; source type: ACTUAL; actual)

Primary completion: 2023-12-22 (precision: day; source type: ACTUAL; actual)

Study completion: 2024-03-12 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:16.980Z; registry revision: 2025-04-16 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT05839509Phase 2 Clinical Trial of GH001 in Bipolar II DisorderTerminatedPhase 2United KingdomSource start: 2023-04-06 (actual)
Source date details

Start: 2023-04-06 (precision: day; source type: ACTUAL; actual)

Primary completion: 2024-11-13 (precision: day; source type: ACTUAL; actual)

Study completion: 2024-12-05 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:16.980Z; registry revision: 2025-02-18 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT05322954Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use DisorderTerminatedPhase 1United StatesSource start: 2023-03-03 (actual)
Source date details

Start: 2023-03-03 (precision: day; source type: ACTUAL; actual)

Primary completion: 2024-03-07 (precision: day; source type: ACTUAL; actual)

Study completion: 2024-03-07 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:16.239Z; registry revision: 2026-05-12 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT05804708Phase 2 Clinical Trial of GH001 in Postpartum DepressionTerminatedPhase 2United Kingdom, NetherlandsSource start: 2023-03-02 (actual)
Source date details

Start: 2023-03-02 (precision: day; source type: ACTUAL; actual)

Primary completion: 2024-08-02 (precision: day; source type: ACTUAL; actual)

Study completion: 2024-11-15 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:16.639Z; registry revision: 2025-02-18 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT05522673[11C]-(R)-Rolipram to Measure cAMP Signaling Before and After KetamineTerminatedPhase 1United StatesSource start: 2023-02-08 (actual)
Source date details

Start: 2023-02-08 (precision: day; source type: ACTUAL; actual)

Primary completion: 2023-02-08 (precision: day; source type: ACTUAL; actual)

Study completion: 2024-01-30 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:16.599Z; registry revision: 2024-03-05 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT05323019Repeated Intranasal Esketamine Plus Almond Therapy in Patients With Treatment Resistant DepressionTerminatedPhase 2CanadaSource start: 2022-10-13 (actual)
Source date details

Start: 2022-10-13 (precision: day; source type: ACTUAL; actual)

Primary completion: 2023-02-01 (precision: day; source type: ACTUAL; actual)

Study completion: 2023-02-01 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:16.239Z; registry revision: 2023-03-24 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT04955470Ketamine Infusion for Rapid Reduction of Suicidality in PediatricsTerminatedPhase 1CanadaSource start: 2022-06-01 (actual)
Source date details

Start: 2022-06-01 (precision: day; source type: ACTUAL; actual)

Primary completion: 2023-09-01 (precision: day; source type: ACTUAL; actual)

Study completion: 2023-10-01 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:15.827Z; registry revision: 2024-12-18 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT05051449Ketamine for OUD and Comorbid Depression (OUDCD)TerminatedPhase 1United StatesSource start: 2022-04-04 (actual)
Source date details

Start: 2022-04-04 (precision: day; source type: ACTUAL; actual)

Primary completion: 2023-11-17 (precision: day; source type: ACTUAL; actual)

Study completion: 2023-11-30 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:15.858Z; registry revision: 2024-03-07 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT04613453Reducing Adolescent Suicide Risk: Safety, Efficacy, and Connectome Phenotypes of Intravenous KetamineTerminatedPhase 2United StatesSource start: 2022-01-21 (actual)
Source date details

Start: 2022-01-21 (precision: day; source type: ACTUAL; actual)

Primary completion: 2024-07-31 (precision: day; source type: ACTUAL; actual)

Study completion: 2024-12-03 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:15.458Z; registry revision: 2025-08-26 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT05193318KAP for Depression in Abstinent Opioid UsersTerminatedPhase 2United StatesSource start: 2022-01-13 (actual)
Source date details

Start: 2022-01-13 (precision: day; source type: ACTUAL; actual)

Primary completion: 2023-03-20 (precision: day; source type: ACTUAL; actual)

Study completion: 2023-03-20 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:16.228Z; registry revision: 2024-05-06 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT05095792Effect of Ketamine on Neurological Activity as Measured by Electroencephalogram (EEG)TerminatedNot reportedUnited StatesSource start: 2021-11-09 (actual)
Source date details

Start: 2021-11-09 (precision: day; source type: ACTUAL; actual)

Primary completion: 2022-10-21 (precision: day; source type: ACTUAL; actual)

Study completion: 2022-10-21 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:15.858Z; registry revision: 2024-11-14 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT04784143Study Comparing Two Versus Three Active MDMA-assisted Sessions in U.S. Military Veterans With Chronic PTSDTerminatedPhase 2United StatesSource start: 2021-11-08 (actual)
Source date details

Start: 2021-11-08 (precision: day; source type: ACTUAL; actual)

Primary completion: 2024-06-25 (precision: day; source type: ACTUAL; actual)

Study completion: 2024-06-27 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:15.488Z; registry revision: 2025-07-15 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT04424225Visual Surround Suppression and Perceptual Expectation Under PsilocybinTerminatedPhase 1United StatesSource start: 2021-08-30 (actual)
Source date details

Start: 2021-08-30 (precision: day; source type: ACTUAL; actual)

Primary completion: 2023-09-01 (precision: day; source type: ACTUAL; actual)

Study completion: 2023-09-01 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:15.107Z; registry revision: 2025-06-27 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT04905121Phase 1b Study in Patients With Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)TerminatedPhase 1United KingdomSource start: 2021-08-11 (actual)
Source date details

Start: 2021-08-11 (precision: day; source type: ACTUAL; actual)

Primary completion: 2022-04-22 (precision: day; source type: ACTUAL; actual)

Study completion: 2022-04-22 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:15.827Z; registry revision: 2022-10-12 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT04429685The Effects of Low Dose Ketamine on Cardiovascular FunctionTerminatedPhase 1United StatesSource start: 2020-11-01 (actual)
Source date details

Start: 2020-11-01 (precision: day; source type: ACTUAL; actual)

Primary completion: 2021-05-28 (precision: day; source type: ACTUAL; actual)

Study completion: 2021-05-28 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:15.458Z; registry revision: 2024-05-21 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT04353921PSIL201 Long-term Follow-up Study: Psilocybin or Niacin / Major Depressive DisorderTerminatedNot reportedUnited StatesSource start: 2020-06-30 (actual)
Source date details

Start: 2020-06-30 (precision: day; source type: ACTUAL; actual)

Primary completion: 2022-10-18 (precision: day; source type: ACTUAL; actual)

Study completion: 2022-10-18 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:15.107Z; registry revision: 2026-05-04 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT04280055Prophylactic Effects of Psilocybin on Chronic Cluster HeadacheTerminatedPhase 1DenmarkSource start: 2020-01-21 (actual)
Source date details

Start: 2020-01-21 (precision: day; source type: ACTUAL; actual)

Primary completion: 2020-11-01 (precision: day; source type: ACTUAL; actual)

Study completion: 2022-06-01 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:15.107Z; registry revision: 2022-08-10 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT04082858Ketamine Interleaved With Electroconvulsive Therapy for DepressionTerminatedPhase 1IrelandSource start: 2020-01-06 (actual)
Source date details

Start: 2020-01-06 (precision: day; source type: ACTUAL; actual)

Primary completion: 2020-06-03 (precision: day; source type: ACTUAL; actual)

Study completion: 2020-06-03 (precision: day; source type: ACTUAL; actual)

Observation retrieved: 2026-10-31T20:06:15.077Z; registry revision: 2021-09-09 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Other substance hubs

Psilocybin | MDMA | LSD | DMT | 5-MeO-DMT | Ayahuasca | Ketamine | Ibogaine

Registry status hubs

Recruiting | Not yet recruiting | Active, not recruiting | Enrolling by invitation | Completed | Suspended | Withdrawn

Phase hubs

Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Phase not applicable

All trial hubs | Learn | Disclaimer